Beijing Tiantan Biological Products Co., Ltd.
600161
Rangering i aksjer
#4321
Beijing Tiantan Biological Products Co., Ltd., established in 1998 and... Beijing Tiantan Biological Products Co., Ltd., established in 1998 and headquartered in Beijing, China, is actively involved in the full spectrum of blood product operations within China. This includes pioneering research and development, manufacturing, sales, and providing consultancy services. Its comprehensive product line features critical blood-derived medicines such as intravenous immunoglobulin, human albumin, and various specialized human immunoglobulins for conditions like hepatitis B (both standard and freeze-dried formulations) and tetanus, alongside other general human immunoglobulin preparations and intravenous blood system solutions. The company operates as a subsidiary of China National Biotec Group Company Limited.
Aksjekurs
$1.81
Markedsverdi
$3.59B
Endring (1 dag)
-0.90%
Endring (1 år)
-32.39%
Land
CN
Handel Beijing Tiantan Biological Products Co., Ltd. (600161)
Kategori
Healthcare
Aksjeprishistorikk for Beijing Tiantan Biological Products Co., Ltd. (600161)
Høyeste sluttskurs: $1.81 den 2026-10-01
Laveste sluttskurs: $0.07 den 2005-07-01
Laveste sluttskurs: $0.07 den 2005-07-01
Aksjeprishistorikk for Beijing Tiantan Biological Products Co., Ltd. fra 2005 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | -10.60% |
| 2025 | -18.04% |
| 2024 | -20.40% |
| 2023 | 33.59% |
| 2022 | -13.56% |
| 2021 | -28.42% |
| 2020 | 98.85% |
| 2019 | 45.59% |
| 2018 | -15.66% |
| 2017 | 10.41% |
| 2016 | 19.78% |
| 2015 | 5.68% |
| 2014 | 24.08% |
| 2013 | 90.14% |
| 2012 | -27.39% |
| 2011 | -24.78% |
| 2010 | -11.65% |
| 2009 | 89.78% |
| 2008 | -47.45% |
| 2007 | 135.81% |
| 2006 | 373.09% |
| 2005 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $534.84 | 25.42% |
US
|
|
| $189.00 | 603.91% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $888.12 | 9.08% |
NL
|
